Prevalence and Risk Factors of Hepatitis B Virus Infection among a Cohort of Primary Health Care Workers in Nigeria
Abstract:
Hepatitis B Virus (HBV) infection is one of the most infectious diseases globally. Nigeria is among the endemic countries for HBV, with a National prevalence of 11%. The Primary Healthcare Center (PHC) is critical for interrupting the transmission of HBV infection. Consequently, the baseline information concerning the prevalence, associated risk factors, and vaccination status of the health workers for HBV is required for the system strengthening, hence, the need for this study. To determine the prevalence of HBV among health workers in PHCs in AMAC, Abuja. 2. To identify the risk factors associated with HBV infection amongst this cohort. A hospital-based cross-sectional descriptive study involving 168 randomly selected PHC health workers. Data was collected with a structured questionnaire, and participants were screened for HBsAg. Data were analyzed using SPSS version 21.0 with results significant at p-value < 0.05. 168 respondents participated in the study, 65.5% were females, and the mean age was 34 +/- 9 years. The full vaccination rate was 44%, while the prevalence of HBV infection was 4.8%. The history of dental procedure was the only significant predictor of HBV infection, and those who had the dental procedure were thrice more likely to be infected with HBV than their counterparts (OR: 3.077). The prevalence of HBV in this study is low, per, National prevalence, but high for this cohort of health workers with a considerable Hepatitis B vaccination rate. There is a need to strengthen health workers' HBV screening and vaccination in addition to improving infection prevention and control in dental clinics/surgeries.Keywords: HBV Infection, Health-worker, Primary Healthcare Center, Prevalence, Risk Factors.
References:
[1] World Health Organization. Guidelines for the prevention, care,
and treatment of persons with chronic hepatitis B infection [internet]. 2015 [cited Feb 2021]. Available
from www.who.int/hepatitis/publications/hepatitis-b-guidelines/en/.
[2] World Health Organization. Global alert response:
Hepatitis B [internet]. 2014 [cited Feb 2021]. Available from http://www.who.int/csr/disease/hepatitis/whocdscsrlyo20022/en/index2.html.
[3] Mukhtar I. G, Yakasai, B.W, Muhammad S. M, Salisu
A. I. 2018. Prevalence of hepatitis b virus surface antigen and hepatitis c virus
antibody among prospective blood donors at Murtala Muhammad specialist hospital,
kano, Nigeria. Journal of Pure and Applied Sciences. 4 (1): 170-176. Available
from https://www.researchgate.net/publication/329591929.
[4]
World Health
Organization. Global hepatitis report, 2017 [internet]. 2017 [cited Feb 2021]. Available
from www.who.int/hepatitis/publications/global-hepatitis-report2017/en/.
[5] World Health Organization. Hepatitis B, Key
Facts [internet]. 2019 [cited Feb 2021]. Available from www.who.int/news-room/fact-sheets/detail/hepatitis-b.
[6] Schad V.A. Global prevalence of hepatitis B virus (HBV) infection in 2016 estimated [internet]. 2018 [cited Feb 2021]. Available from https://www.infectiousdiseaseadvisor.com/home/advisor-channels/hepatitis-advisor/global-prevalence-of-hepatitis-b-virus-infection-in-2016-estimated/.
[7] Abutu A. Nigeria’s complicated hepatitis burden.
The lancet. Gastroenterology & hepatology. 2018; 3
(10): 669. Available from DOI: doi.org/10.1016/S2468-1253 (18)30279-.
[8] Orji I. A, & Okoli U. T. Prevalence of Hepatitis-B infection among Pregnant Women in a Primary Healthcare
Centre in Abuja, Nigeria. Texila
International Journal of Public Health. 2016; 4 (4): Art. 57. Available from DOI: 10.21522/TIJPH.2013.04.04.
[9] Anaedobe CG, Fowotade A, Omoruyi CE, Bakare
RA. 2015. Prevalence, socio-demographic features, and risk factors of Hepatitis
B virus infection among pregnant women in Southwestern Nigeria. Pan African Medical
Journal. 20: 406. Available from www.panafrican-med-journal.com/content/article/20/406/full/
doi:10.11604/pamj.2015.20.406.6206.
[10] Yakasai IB, Ayuba R, Abubakar IS, Ibrahim SA.
2012 Jan-Dec; Sero-prevalence of Hepatitis B Virus Infection and its Risk factors
among Pregnant Women Attending Antenatal Clinic at Aminu Kano Teaching Hospital,
Kano, Nigeria. Journal of Basic and Clinical Reproductive Sciences. 1 (1
& 2). Available from www.jbcrs.org DOI: 10.4103/2278-960X.104297.
[11] Esan A.J, Omisakin C.T, Ojo-Bola T, Wooden M.F,
Fasakin K.A, Ogunleye A. A. 2014; Sero- Prevalence of Hepatitis B and Hepatitis
C Virus Co-Infection among Pregnant Women in Nigeria. American Journal of Biomedical
Research. 2 (1): 11-15. Available from http://pubs.sciepub.com/ajbr/2/1/3.
[12] Desalegn Z, Mihret A, Beyene H.B, Yilma M, Seid
Y, Tamiru W, et al. 2016; Survey of Hepatitis B virus infection and risk factors
among pregnant women at public hospital in Ethiopia. International Journal of
Biomedical Research. 7(7): 450-456. Available from DOI: 10.7439/ijbr.
[13] Tanga AT, Teshome MA, Hiko D, Fikru C, Jilo
GK. 2019; Sero-prevalence of hepatitis B virus and associated factors among pregnant
women in Gambella hospital, South-western Ethiopia: facility based cross-sectional
study. BMC Infectious Diseases. 19: 602 Available from https://doi.org/10.1186/s12879-019-4220-z.
[14] Osman A.M.M, Mirghani O.A, Gasim G.I, Adam I.
2014; Hepatitis B Virus, Hepatitis C Virus, and Human Immunodeficiency Virus Infections
among Pregnant Women in Central Sudan. Sudan Journal of Medical Sciences.
9 (2): 91-96.
[15] Coste M., De Sèze M., Diallo A., et al. 2019;
Burden and impacts of chronic hepatitis B infection in rural Senegal: study protocol
of a cross-sectional survey in the area of Niakhar (AmBASS ANRS 12356). BMJ Open.
9: e030211. Available from doi:10.1136/ bmjopen-2019-030211.
[16] Rabiu KA, Akinola OI, Adewunmi AA, Omololu OM,
Ojo TO. 2010 Aug; Risk factors for hepatitis B virus infection among pregnant women
in Lagos, Nigeria. Acta Obstetrician Et Gynecologica Scandinavica. 89: 1024–1028.
Available from https://www.researchgate.net/publication/45268763.
DOI: 10.3109/00016349.2010.482580.
[17] Glen S. Sample size in statistics (How to find
it): Excel, Cochran’s formula, general tips. From Statistics HowTo.com: Elementary
statistics for the rest of us [internet]. 2020 [cited March 2021]. Available from
https://www.statisticshowto.com/probability-and-statistics/find-sample-size/.
[18] Ola SO, Odaibo GN, Olaleye OD, et al. 2012;
Hepatitis B and E viral infections among Nigerian healthcare workers. Afr J Med
Sci. 41: 387–391.
[19] Mueller A, Stoetter L, Kalluvya S, Stich A, Majinge C, Weissbrich
B, Kasang C. 2015 Sep 23; Prevalence of hepatitis B virus infection among health
care workers in a tertiary hospital in Tanzania. BMC Infect Dis. 15:386.
doi: 10.1186/s12879-015-1129-z. PMID: 26399765; PMCID: PMC4581415.
[20] Alqahtani JM, Abu-Eshy SA, Mahfouz AA, et al.
Sero-prevalence of hepatitis B and C virus infections among health students and
health care workers in the Najran region, southwestern Saudi Arabia: the need for
national guidelines for health students. BMC Pub Health 2014; 14: 577.
[21] Bonani P and Bonnacorssi G. Vaccination against
hepatitis B in health care workers. Vaccine 2001; 19: 2389–2394.
[22] Kateera F, Walker TD, Mutesa L, et al. 2015;
Hepatitis B and C seroprevalence among health care workers in a tertiary hospital
in Rwanda. Trans R Soc Trop Med Hyg. 109: 203–208.
[23] Orji CJ, Chime OH, Ndibuagu EO. 2020; Vaccination
status and prevalence of hepatitis B virus infection among health-care workers in
a tertiary health institution, Enugu State, Nigeria. Proceedings of Singapore Healthcare.
29(2): 119-125. doi:10.1177/2010105820923681.
[24] Elzouki AN, Elgamay SM, Zorgani A, et al. 2014;
Hepatitis B and C status among health care workers in the five main hospitals in
eastern Libya. Infect Pub Health 7: 534–541.
[25] Rybacki M, Piekarska A, Wiszniewska M, et al.
2013; Hepatitis B and C infection: is it a problem in Polish healthcare workers?
Int J Occup Med Environ Health 26: 430–439.
[26] Ciorlia LA, Zanetta DM. 2005 Oct; Hepatitis B in healthcare workers:
prevalence, vaccination, and relation to occupational factors. Braz J Infect
Dis. 9(5):384-9. doi: 10.1590/s1413-86702005000500005. Epub 2006 Jan 6. PMID:
16410889.
[27] Hussein N.R. 2018; Risk factors of hepatitis B virus infection
among blood donors in Duhok city, Kurdistan Region, Iraq. Caspian J Intern Med.
9(1):22-26. doi:10.22088/cjim.9.1.22.
[28] Molla S, Munshea A & Nibret E. 2015; Seroprevalence
of hepatitis B surface antigen and anti HCV antibody and its associated risk factors
among pregnant women attending maternity ward of Felege Hiwot Referral Hospital,
northwest Ethiopia: a cross-sectional study. Virol J. 12: 204. https://doi.org/10.1186/s12985-015-0437-7.
[29] Tiruye G, Shiferaw K, Tadesse F. 2018; Seroprevalence of Hepatitis
B Virus Infection and Associated Factors among Pregnant Women Attended Antenatal
Care Services in Harar City, Eastern Ethiopia. J Women's Health Care, 7:
436. doi:10.4172/2167-0420.1000436 P.
[30] Olayinka AT, Oyemakinde A, Balogun MS, Ajudua A, Nguku P, Aderinola
M, Egwuenu-Oladejo A, Ajisegiri SW, Sha'aibu S, Musa BO, Gidado S, Nasidi A. 2016
Oct 5; Seroprevalence of Hepatitis B Infection in Nigeria: A National Survey. Am
J Trop Med Hyg. 95(4):902-907. doi: 10.4269/ajtmh.15-0874. Epub 2016 Aug 15.
PMID: 27527630; PMCID: PMC5062798.
[31] Umare A, Seyoum B, Gobena T, Haile Mariyam T. 2016; Hepatitis
B Virus Infections and Associated Factors among Pregnant Women Attending Antenatal
Care Clinic at Deder Hospital, Eastern Ethiopia. PLoS One. 11(11): e0166936.
https://doi.org/10.1371/journal.pone.0166936.
[32] Mahboobi N, Porter SR, Karayiannis P, Alavian SM. 2013 Mar; Dental treatment as a risk factor for hepatitis B and C viral infection. A review of recent literature. J Gastrointestin Liver Dis. 22(1):79-86. PMID: 23539395.